floxacillin has been researched along with ppi-0903 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreoni, F; Eberl, L; François, P; Kalawong, R; Mairpady Shambat, S; Menzi, C; Toyofuku, M; Zinkernagel, AS | 1 |
| Gutheil, WG; Sharma, AD | 1 |
2 other study(ies) available for floxacillin and ppi-0903
| Article | Year |
|---|---|
Antibiotics Stimulate Formation of Vesicles in
Topics: Anti-Bacterial Agents; Bacteriophages; Ceftaroline; Cephalosporins; Cytoplasmic Vesicles; Daptomycin; DNA, Bacterial; Floxacillin; Humans; Lysogeny; Peptidoglycan; Staphylococcus aureus | 2019 |
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cloxacillin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2023 |